European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. / Sweet, David G.; Carnielli, Virgilio; Greisen, Gorm; Hallman, Mikko; Ozek, Eren; Te Pas, Arjan; Plavka, Richard; Roehr, Charles C.; Saugstad, Ola D.; Simeoni, Umberto; Speer, Christian P.; Vento, Maximo; Visser, Gerhard H.A.; Halliday, Henry L.

I: Neonatology, Bind 115, Nr. 4, 2019, s. 432-450.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Sweet, DG, Carnielli, V, Greisen, G, Hallman, M, Ozek, E, Te Pas, A, Plavka, R, Roehr, CC, Saugstad, OD, Simeoni, U, Speer, CP, Vento, M, Visser, GHA & Halliday, HL 2019, 'European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update', Neonatology, bind 115, nr. 4, s. 432-450. https://doi.org/10.1159/000499361

APA

Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., Te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., Simeoni, U., Speer, C. P., Vento, M., Visser, G. H. A., & Halliday, H. L. (2019). European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. Neonatology, 115(4), 432-450. https://doi.org/10.1159/000499361

Vancouver

Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A o.a. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. Neonatology. 2019;115(4):432-450. https://doi.org/10.1159/000499361

Author

Sweet, David G. ; Carnielli, Virgilio ; Greisen, Gorm ; Hallman, Mikko ; Ozek, Eren ; Te Pas, Arjan ; Plavka, Richard ; Roehr, Charles C. ; Saugstad, Ola D. ; Simeoni, Umberto ; Speer, Christian P. ; Vento, Maximo ; Visser, Gerhard H.A. ; Halliday, Henry L. / European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. I: Neonatology. 2019 ; Bind 115, Nr. 4. s. 432-450.

Bibtex

@article{bacf14967d0143ffa96b58bf5924608a,
title = "European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update",
abstract = "As management of respiratory distress syndrome (RDS) advances, clinicians must continually revise their current practice. We report the fourth update of {"}European Guidelines for the Management of RDS{"} by a European panel of experienced neonatologists and an expert perinatal obstetrician based on available literature up to the end of 2018. Optimising outcome for babies with RDS includes prediction of risk of preterm delivery, need for appropriate maternal transfer to a perinatal centre and timely use of antenatal steroids. Delivery room management has become more evidence-based, and protocols for lung protection including initiation of CPAP and titration of oxygen should be implemented immediately after birth. Surfactant replacement therapy is a crucial part of management of RDS, and newer protocols for its use recommend early administration and avoidance of mechanical ventilation. Methods of maintaining babies on non-invasive respiratory support have been further developed and may cause less distress and reduce chronic lung disease. As technology for delivering mechanical ventilation improves, the risk of causing lung injury should decrease, although minimising time spent on mechanical ventilation using caffeine and, if necessary, postnatal steroids are also important considerations. Protocols for optimising general care of infants with RDS are also essential with good temperature control, careful fluid and nutritional management, maintenance of perfusion and judicious use of antibiotics all being important determinants of best outcome.",
keywords = "Antenatal steroids, Continuous positive airway pressure, Evidence-based practice, Hyaline membrane disease, Mechanical ventilation, Nutrition, Oxygen supplementation, Patent ductus arteriosus, Preterm infant, Respiratory distress syndrome, Surfactant therapy, Thermoregulation",
author = "Sweet, {David G.} and Virgilio Carnielli and Gorm Greisen and Mikko Hallman and Eren Ozek and {Te Pas}, Arjan and Richard Plavka and Roehr, {Charles C.} and Saugstad, {Ola D.} and Umberto Simeoni and Speer, {Christian P.} and Maximo Vento and Visser, {Gerhard H.A.} and Halliday, {Henry L.}",
year = "2019",
doi = "10.1159/000499361",
language = "English",
volume = "115",
pages = "432--450",
journal = "Neonatology",
issn = "1661-7800",
publisher = "S Karger AG",
number = "4",

}

RIS

TY - JOUR

T1 - European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update

AU - Sweet, David G.

AU - Carnielli, Virgilio

AU - Greisen, Gorm

AU - Hallman, Mikko

AU - Ozek, Eren

AU - Te Pas, Arjan

AU - Plavka, Richard

AU - Roehr, Charles C.

AU - Saugstad, Ola D.

AU - Simeoni, Umberto

AU - Speer, Christian P.

AU - Vento, Maximo

AU - Visser, Gerhard H.A.

AU - Halliday, Henry L.

PY - 2019

Y1 - 2019

N2 - As management of respiratory distress syndrome (RDS) advances, clinicians must continually revise their current practice. We report the fourth update of "European Guidelines for the Management of RDS" by a European panel of experienced neonatologists and an expert perinatal obstetrician based on available literature up to the end of 2018. Optimising outcome for babies with RDS includes prediction of risk of preterm delivery, need for appropriate maternal transfer to a perinatal centre and timely use of antenatal steroids. Delivery room management has become more evidence-based, and protocols for lung protection including initiation of CPAP and titration of oxygen should be implemented immediately after birth. Surfactant replacement therapy is a crucial part of management of RDS, and newer protocols for its use recommend early administration and avoidance of mechanical ventilation. Methods of maintaining babies on non-invasive respiratory support have been further developed and may cause less distress and reduce chronic lung disease. As technology for delivering mechanical ventilation improves, the risk of causing lung injury should decrease, although minimising time spent on mechanical ventilation using caffeine and, if necessary, postnatal steroids are also important considerations. Protocols for optimising general care of infants with RDS are also essential with good temperature control, careful fluid and nutritional management, maintenance of perfusion and judicious use of antibiotics all being important determinants of best outcome.

AB - As management of respiratory distress syndrome (RDS) advances, clinicians must continually revise their current practice. We report the fourth update of "European Guidelines for the Management of RDS" by a European panel of experienced neonatologists and an expert perinatal obstetrician based on available literature up to the end of 2018. Optimising outcome for babies with RDS includes prediction of risk of preterm delivery, need for appropriate maternal transfer to a perinatal centre and timely use of antenatal steroids. Delivery room management has become more evidence-based, and protocols for lung protection including initiation of CPAP and titration of oxygen should be implemented immediately after birth. Surfactant replacement therapy is a crucial part of management of RDS, and newer protocols for its use recommend early administration and avoidance of mechanical ventilation. Methods of maintaining babies on non-invasive respiratory support have been further developed and may cause less distress and reduce chronic lung disease. As technology for delivering mechanical ventilation improves, the risk of causing lung injury should decrease, although minimising time spent on mechanical ventilation using caffeine and, if necessary, postnatal steroids are also important considerations. Protocols for optimising general care of infants with RDS are also essential with good temperature control, careful fluid and nutritional management, maintenance of perfusion and judicious use of antibiotics all being important determinants of best outcome.

KW - Antenatal steroids

KW - Continuous positive airway pressure

KW - Evidence-based practice

KW - Hyaline membrane disease

KW - Mechanical ventilation

KW - Nutrition

KW - Oxygen supplementation

KW - Patent ductus arteriosus

KW - Preterm infant

KW - Respiratory distress syndrome

KW - Surfactant therapy

KW - Thermoregulation

U2 - 10.1159/000499361

DO - 10.1159/000499361

M3 - Review

C2 - 30974433

AN - SCOPUS:85064351036

VL - 115

SP - 432

EP - 450

JO - Neonatology

JF - Neonatology

SN - 1661-7800

IS - 4

ER -

ID: 236322816